Principal and General Manager, PwC US
Mark is the General Manager of PwC’s DoubleJump™ Interchange. He is also a Principal in the Strategy& practice within PwC’s Health Industries Advisory group. Mark has over 25 years of experience improving organizational performance across biopharmaceutical, medical device, diagnostics, and academic research organizations. Over the last decade, Mark has focused on applying novel technologies and operating models to develop precision therapies and to deliver personalized healthcare in the New Health Economy.